EISSN 2148-5607

TJG IS INDEXED IN SCI-EXPANDED AND PUBMED IMPACT FACTOR: 1.4

Turkish Journal of Gastroenterology

35 414 2024

Submission to First Decision = 31 Days

HIGHLY CITED ARTICLES

HBV and HCV are the risk factors in CCA

Tan et al.

Serum resolvin levels in irritable bowel syndrome

Karatay and Gül Utku

Microbial improvement after intervention

Qian et al.

18F-FDGPET/CT in gallbladder carcinoma

Arslan et al.

Bezoar in endoscopy

Gökbulut et al.

Effect of vitamin D on CD40L gene expression in UC

Sharifi et al.

ERCP for acute cholangitis

Khamaysi and Taha

Inborn metabolic causes of fatty liver disease

Yıldız and Sivri

Gastric and small intestinal TSA

Kiremitci et al.

COVID-19 in Hepatology and Liver transplantation

Kabaçam et al.

Editorial

Assessment of intestinal permeability using 51CrEDTA in inflammatory bowel disease

Gülen ARSLAN ¹ , Mehmet CİNDORUK ² , Tamer ATASEVER ³ , İ. Safa YILDIRIM ⁴

Author Affiliation(s)

1.

Social Security Hospital, Departments of Internal Medicine, Ankara

2.

Departments of Gastroenterology Clinical Infectious Diseases, Gazi University, School of Medicine, Ankara

3.

Gazi Üniversitesi Tıp Fakültesi Gastroenteroloji Bilim Dalı ve Nükleer Tıp Anabilim Dalı, Ankara

4.

Bilim Dalları, SSK Ankara Eğitim Hastanesi Dahiliye Kliniği

Turk J Gastroenterol 2000; 11: 0-0

Keywords : İntestinal permeabilite, inflammatuvar barsak hastalıkları, 51CrEDTA.

Read: 1369 Published: 25 July 2019

Volume 11, Issue 4, December 2000

Previous Article